Mitsubishi Tanabe Launches Take Over Bid For Generics Maker Choseido Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma announced May 7 it will acquire over 50 percent stake of Tokushima-based generic drugmaker Choseido Pharmaceutical. The move is believed to strengthen Mitsubishi Tanabe's position in the generics market, generic product lineup and allows Choseido to utilize Mitsubishi Tanabe's marketing and distribution channels. Mitsubishi Tanabe is in ongoing conversations with Choseido about acquiring additional shares. (Click here for more - Japanese language